Companies
Amgen
S&P 500Health Care· USA

AMGN

Status-Quo-Player

Amgen

$349.82

-0.33%

Open $352.09·Prev $351.00

as of 13 Apr

STATUS-QUO-PLAYER

Power Core

Amgen's moat is its vertically integrated biologics manufacturing network, which converts capital intensity into a durable competitive barrier that scales with regulatory complexity.

Published1 Apr 2026
UniverseS&P 500
SectorHealth Care

Direction of Movement

Lateral, Awaiting MariTide Data and Deleveraging Progress

ROC 200

+17.7%

Referenced in 22 other analyses
This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.
AMGN — Amgen — Power Mapping Analysis — L17X — L17X